ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT

Clinical trials for ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT trials appear

Sign up with your email to follow new studies for ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gut shield: new drug may prevent infections after bone marrow transplant

Disease control Ongoing

This study tests an oral drug called SYN-004 in 36 adults who have had a bone marrow transplant and need strong antibiotics. The goal is to see if SYN-004 is safe, protects the gut's healthy bacteria, and helps prevent serious infections. Participants take SYN-004 along with thei…

Matched conditions: ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT

Phase: PHASE1, PHASE2 • Sponsor: Theriva Biologics, Inc. • Aim: Disease control

Last updated May 18, 2026 12:04 UTC

ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT

Get alerted when new ACUTE GRAFT-VERSUS-HOST REACTION FOLLOWING BONE MARROW TRANSPLANT trials appear

Gut shield: new drug may prevent infections after bone marrow transplant